ROCHESTER, Mich., Nov. 28, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced that management will participate in the following upcoming investor conferences:
- Piper Sandler 34th Annual Healthcare Conference, New York City, November 29th – December 1st 2022
- J.P. Morgan Healthcare Conference, San Francisco, January 9th – January 12th 2023
- LifeSci Partners Corporate Access Event, San Francisco, January 9th – January 12th 2023
|Piper Sandler 34th Annual Healthcare Conference|
|Date:||Wednesday, November 30th|
|Time:||8:00 AM ET|
|Location:||Lotte New York Palace|
|Room:||Holmes 1, 4th Floor|
Management will also be available for one-on-one meetings. To request a meeting or for more details about the conference please reach out to your institutional contact or email: firstname.lastname@example.org.
|J.P. Morgan Healthcare Conference|
|Date:||Thursday, January 12th|
|Time:||8:15 AM PT|
|Location:||The Westin St. Francis|
For more details about the conference or to request an in-person meeting please contact your institutional contact or email: email@example.com.
|LifeSci Partners Corporate Access Event|
|Date:||Wednesday, January 11th|
|Format:||1-on-1 In-Person Meetings|
|Location:||Beacon Grand (Formerly Sir Francis Drake Hotel)|
For more information about the event or to request a meeting please register here.
OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through the most intelligent technology platform embedded within a proprietary digital point-of-care network, OptimizeRx helps patients start and stay on their medications.
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify these forward-looking statements. All statements that reflect the Company’s expectations, assumptions, projections, beliefs or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Company’s growth, business plans and future performance. These forward-looking statements are based on the Company’s current expectations and assumptions regarding the Company’s business, the economy, and other future conditions. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other risks summarized in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, its subsequent Quarterly Reports on Form 10-Q, and its other filings with the Securities and Exchange Commission.
Andy D’Silva, SVP Corporate Finance
Media Relations Contact
Kimberley Sirk, Media Relations Manager
Investor Relations Contact
LifeSci Advisors, LLC